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ABSTRAK
Tujuan: mengetahui perbedaan kadar IL-6 dan protein C reaktif antara kelompok infeksi dengue dengan dan 
tanpa kebocoran plasma. Metode: penelitian potong lintang terhadap penderita infeksi dengue yang dirawat di RS 
Cipto Mangunkusomo dan RS Persahabatan antara 1 Maret 2014 - 1 April 2015 dengan menganalisis perbedaan 
kadar IL-6 dan protein C reaktif pada hari ke-3 dan ke-5 demam antara kedua kelompok, maupun pada tiap 
kelompok. Kadar IL-6 dan protein C reaktif pada kedua kelompok dianalisis menggunakan uji t tidak berpasangan 
atau Mann-Whitney, dan pada masing-masing kelompok dianalisis dengan uji t berpasangan atau Wilcoxon. Hasil: 
sampel yang diteliti terdiri atas 24 orang dengan kebocoran plasma dan 20 orang tanpa kebocoran plasma. Kadar 
IL-6 pada kelompok dengan dan tanpa kebocoran plasma pada hari ke-3 dan ke-5 demam adalah 8,56 (1,85-96,15) 
vs. 3,80 (1,94-81,93) pg/mL (p=0,069) dan 4,30 (1,60-70,28) vs. 2,76 (1,26-11,67) pg/mL (p=0,025), sedangkan 
untuk protein C reaktif adalah 10,1 (4,3-36,5) vs. 6,8 (3,0-21,6) mg/L (p=0,014) dan 5,0 (2,0-20,1) vs. 2,9 (0,1-
9,9) mg/L (p=0,048). Kadar IL-6 hari ke-3 dan ke-5 demam pada kelompok dengan dan tanpa kebocoran plasma 
adalah 8,56 (1,85-96,15) vs. 4,30 (1,60-70,28) pg/mL (p=0,037) dan 3,80 (1,94-81,93) vs. 2,76 (1,26-11,67) pg/mL 
(p=0,005). Kadar protein C reaktif hari ke-3 dan ke-5 demam pada kelompok dengan dan tanpa kebocoran plasma 
adalah 10,1 (4,3-36,5) vs. 5,0 (2,0-20,1) mg/L (p=0,0001) dan 6,8 (0,3-21,6) vs. 2,9 (0,1-9,9) mg/L (p=0,0001). 
Kesimpulan: pada hari ke-3 demam kadar IL-6 tidak berbeda antara kedua kelompok, sedangkan pada hari 
ke-5 demam, kadar IL-6 lebih tinggi pada kelompok dengan kebocoran plasma. Kadar protein C reaktif hari ke-3 
dan ke-5 demam lebih tinggi pada kelompok dengan kebocoran plasma. Kadar IL-6 dan protein C reaktif kedua 
kelompok lebih tinggi pada hari ke-3 dibandingkan hari ke-5 demam.
Kata kunci: interleukin-6, protein C reaktif, dengue, kebocoran plasma.
ABSTRACT
Aim: to determine the differences in IL-6 and CRP levels among groups of dengue infection patients with and 
without plasma leakage. Methods: a cross-sectional study was conducted in adult patients with dengue infection 
who were treated at Cipto Mangunkusumo and Persahabatan Hospital between 1 March 2014 and 1 April 2015. 
The study analyzed differences in IL-6 and CRP levels on the 3rd and 5th day of fever in both groups, as well as 
differences in each group. Interleukin-6 and CRP levels in both groups, was analyzed using unpaired t-test or Mann-
Whitney and in each group, the data was subsequently analyzed using paired t-test or Wilcoxon test. Results: the 
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samples of study consisted of 24 subjects with plasma leakage and 20 subjects without plasma leakage. The level 
of IL-6 for groups with and without plasma leakage for the 3rd and the 5th day of fever were 8.56 (1.85-96.15) vs. 
3.80 (1.94-81.93) pg/mL (p=0.069) and 4.30 (1.60-70.28) vs. 2.76 (1.26-11.67) pg/mL (p=0.025), respectively; 
while for CRP level, there were 10.1 (4.3-36.5) vs 6.8 (3.0-21.6) mg/L (p=0.014) and 5.0 (2.0-20.1) vs 2.9 (0.1-
9.9) mg/L (p=0.048). The level of IL-6 on the 3rd and the 5th day of fever in the group with and without plasma 
leakage were 8.56 (1.85-96.15) vs. 4.30 (1.60-70.28) pg/mL (p=0.037) and 3.80 (1.94-81.93) vs. 2.76 (1.26-11.67) 
pg/mL (p=0.005). The level of CRP on the 3rd and 5th day of fever in the group with and without plasma leakage 
were 10.1 (4.3-36.5) vs. 5.0 (2.0-20.1) mg/L (p=0.0001) and 6.8 (0.3-21.6) vs. 2.9 (0.1-9.9) mg/L (p=0.0001). 
Conclusion: there was no difference in IL-6 level on the 3rd day of fever between the two groups; while on the 
5th day of fever, the IL-6 level was higher in the group with plasma leakage. The level of CRP on the 3rd and the 
5th day of fever were higher in the group with plasma leakage. The levels of IL-6 and CRP on the 3rd day of fever 
were higher than the levels on the 5th day of fever in both groups.
Keywords: interleukin-6, C-reactive protein, dengue, plasma leakage.
INTRODUCTION
Until now, dengue infection still is an 
important health problem, either worldwide1 or 
in Indonesia.2 Dengue fever (DF) and dengue 
hemorrhagic fever (DHF) are the most common 
manifestations of dengue infection. DF is a 
mild feature of the disease without plasma 
leakage; while DHF is a form of severe disease, 
accompanied by plasma leakage in critical phase.3 
Plasma leakage in DHF may include increased 
hematocrit, hypoalbuminemia as well as serous 
effusion in the pleural, pericardial and peritoneal 
cavities.4,5 Poor treatment will cause dengue shock 
syndrome (DSS) and its mortality rate worldwide 
is still relatively high, i.e. 5-30%.6 According to 
the immunopathogenesis theory, plasma leakage 
in DHF/DSS is a result of cytokine storm reaction 
or multiplication of cytokine production in the 
vascular endothelium.7,8 The theory is supported 
by some studies in children,9-12 which reported 
an association between increased levels of tumor 
necrosis factor (TNF)-α, interleukin (IL)-1β and 
interleukin (IL)-6 with plasma leakage in DHF/
DSS patients. Those three pro-inflammatory 
cytokines also serve as endogenous pyrogen, 
which will have increased levels in each process 
of acute inflammation and can induce synthesis 
of various acute phase proteins such as C-reactive 
protein (CRP).13 The CRP itself is a systemic 
inflammatory marker that is commonly used in 
daily clinical practice and has been acknowledged 
as one of many inflammatory variables.13,14
In adults, few studies have been conducted on 
the pathophysiology of cytokine storm reaction. 
For clinical application, IL-6 is the most relevant 
to be studied among those three pro-inflammatory 
cytokines as it is the main inducer of C-reactive 
protein synthesis.13 Until now, no study has been 
conducted in adult patients to compare the levels 
of IL-6 and CRP between groups of dengue 
infection with and without plasma leakage in 
order to identify the correlation between acute 
inflammatory process and the development of 
plasma leakage. Moreover, the temporal pattern of 
IL-6 and CRP production associated with cytokine 
storm reaction in dengue infection has not been 
known either. Therefore, serial measurements of 
IL-6 and CRP levels in febrile and critical phases 
should be performed since the IL-6 and CRP can 
also increase due to secondary bacterial infection.
In daily practice, we still can find a relatively 
high incidence of antibiotic treatment for patients 
with dengue infection due to a great concern 
on secondary infection caused by bacterial 
translocation from the intestinal lumen into the 
circulation.4,15,16 The peak of febrile phase is on 
the 3rd day of fever; while critical phase usually 
occurs on the 5th day of fever.17 Theoretically, 
the cytokine storm reaction in dengue infection 
occurs during febrile phase and will resolve in 
critical phase.7,8 The theory should be confirmed 
further through clinical studies in adult patients 
with dengue infection. The aim of our study was 
to determine differences in the levels of IL-6 and 
CRP among groups of dengue infection with and 
without plasma leakage.
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METHODS
The present study was a cross-sectional 
study using secondary data from medical records 
and case report form (CRF) of adult patients 
with dengue infection who were hospitalized 
in Cipto Mangunkusumo and Persahabatan 
Hospital between 1 March 2014 and 1 April 
2015. Secondary data collection was performed 
in May – June 2015. The inclusion criteria were 
patients with dengue infection who came to 
the hospital with ≤3-day fever, aged ≥14 years 
and did not receive antibiotic treatment during 
hospitalization; while the exclusion criteria 
were pregnancy, patients with comorbidities 
(hypertension, diabetes mellitus, cardiovascular 
disease, liver cirrhosis, malnutrition with 
hypoalbuminemia, pulmonary edema, ARDS, 
other infectious disease, inflammatory disease, 
malignancy, patients with leukocytosis 
and or neutrophilia), patients who were on 
corticosteroid and immunosuppressant treatment 
and incomplete data.
Samples were obtained in our study 
by consecutive sampling. Sample size was 
determined using estimation formula of sample 
size for different mean value of 2 unpaired 
groups. For IL-6 variable, the minimal sample 
size for each group was 22 subjects with a 
total sample size of 44 subjects; while for CRP 
variable, the minimal sample size for each group 
was 18 subjects and the total sample size was 36 
subjects. Based on both calculations, we took the 
greatest minimal sample size in order to achieve 
the study goal, i.e. 44 subjects.
Our study used secondary data and therefore, 
informed consent was not necessary. Ethical 
approval was issued by the Ethics Committee 
for Medical Research, Faculty of Medicine, 
University of Indonesia with a reference number 
of 443/UN2.F1/ETIK/2015; however, all data 
used for the purpose of the study were kept 
confidential.
Data Collection
Secondary data collected from medical 
record and CRF were basic data (age, sex, 
diagnosis, length of hospitalization), data 
obtained from history taking (duration of fever, 
bleeding manifestation), data from physical 
examination (vital signs, bleeding manifestation, 
pleural effusion, ascites), data from laboratory 
workup (hemoglobin, hematocrit, leukocytes, 
platelet count, albumin, IL-6 and CRP levels), as 
well as data from USG examination (pulmonary 
and abdominal USG).
IL-6 examination was performed by ELISA 
method using Quantikine reagent (R&D Systems, 
Inc); while the examination of CRP was done 
by immunoturbidimetry method using Cobas 
Integra instrument and CRPHS Latex (Roche) 
reagent. The subjects were considered as having 
dengue infection when they had 2-7 days of fever 
and were NS1 positive. Plasma leakage was 
defined when there was pleural effusion or ascites 
confirmed by pulmonary and abdominal USG. 
Statistical Analysis
The collected data was filled into the subject 
form. Next, the data was tabulated into dummy 
table, which was consistent with the aim of the 
study and subsequently the data was edited and 
coded. Afterwards, the data was documented 
into a computerized magnetic disc and was 
processed by a personal computer using SPSS 
22.0 software. The subject characteristic data 
was presented descriptively. Data of IL-6 and 
CRP levels in both groups were analyzed with 
Shapiro-Wilk test to evaluate their distribution 
and unpaired student t-test or Mann-Whitney test 
were used to compare between groups. Data of 
IL-6 and CRP levels on the 3rd and 5th day of 
fever in each group were analyzed using paired 
student t-test or Wilcoxon test. Differences 
between both groups were considered significant 
when the p<0.05.
RESULTS
The number of subjects participated in the 
study were 44 subjects. Subject characteristics 
are presented in Table 1. Mean age of the subjects 
in both groups could be categorized into young 
adults with a proportion of male and female as 
many as 50% respectively. On the 3rd and 5th 
day of fever, we found that the mean hemoglobin 
and hematocrit levels for both groups were still 
within normal limit; while the mean leukocyte 
and platelet counts were lower than normal 
values. On the 3rd day of fever, we found that the 
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mean albumin levels for both groups were also 
still within normal limits, but on the 5th day of 
fever, the value was below normal limits for the 
group with plasma leakage; while for the group 
without plasma leakage, the value was still within 
normal limit. Delta of hematocrit and albumin 
levels was calculated based on differences of 
values on the 3rd and 5th day of fever. The mean 
delta of hematocrit levels in both groups was 
found less than 10%; while the mean delta of 
albumin levels for the group with plasma leakage 
was more than 0.5 g/dL and for the group without 
plasma leakage was less than 0.5 g/dL. 
The levels of IL-6 on the 3rd day of fever was 
not different between the group with and without 
plasma leakage (p>0.05); while on the 5th day of 
fever, it was higher than the group with plasma 
leakage than the group without plasma leakage 
(p<0.05). CRP levels on the 3rd and 5th day were 
higher in the group with plasma leakage compared 
to the group without plasma leakage (p<0.05). 
(Table 2)
The levels of IL-6 in the groups with and 
without plasma leakage were higher on the 3rd 
day of fever than on the 5th day of fever in both 
groups (p<0.05). CRP levels were found higher 
on the 3rd day compared to the 5th day of fever 
in both groups (p< 0.05). (Table 3)








Age (year), mean (SD) 23.7 (8.4) 24.3 (6.5)
Sex (male), n (%) 13 (54.2) 8 (40)
Hemoglobin level (g/dL), mean (SD)
 - The 3rd day 14.3 (2.0) 13.4 (1.3)
 - The 4th day 13.9 (2.0) 13.3 (1.6)
Hematocrit (%), mean (SD)
 - The 3rd day 40.5 (4.9) 39.1 (3.0)
 - The 5th day 39.8 (5.6) 9.5 (4.1)
Leukocytes (103/µL), mean (SD)
 - The 3rd day 3.37 (1.61) 3.02 (1.63)
 - The 5th day 4.53 (2.08) 3.56 (1.51)
Platelets (103/µL), mean (SD)
 - The 3rd day 92.83 (30.89) 109.30 (31.47)
 - The 5th day 4.88 (22.34) 60.00 (22.88)
Albumin level (g/dL), mean (SD)
 - The 3rd day 3.81 (0.26) 3.78 (0.25)
 - The 5th day 3.30 (0.39) 3.50 (0.30)
Delta Hematokrit (%), 
mean (SD) 10.96 (6.59) 7.09 (4.37)
Delta Albumin (g/dL), 
mean (SD) 0.55 (0.33) 0.31 (0.26)
Table 2. Differences in interleukin-6 and CRP levels 
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Table 3. The levels of interleukin-6 and CRP on the 3rd 
and the 5th day of fever
Variables
On the 3rd 
day
(n=44)




IL-6 level (pg/mL), median (range)













CRP level (mg/L), median (range)















The mean age of subjects in both groups is 
still included in the group of young age, which is 
consistent with a study conducted by Bhaskar et 
al.4 In few last decades, there are epidemiological 
changes of dengue infection in Indonesia, i.e. 
there are a higher number of dengue infection 
cases in the age group over 15 years of age.15 
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Similar data has also been shown by other Asian 
countries such as Singapore, which in 1990-1996 
demonstrated the highest morbidity rate in the 
15-34 years age group and Bangladesh which 
during the epidemic dengue in 2000 found the 
highest proportion cases in the 18-33 years 
age group.18 The proportion between male and 
female subjects in our study is similar, which is 
consistent with reports from Malaysia and South 
America.18
The mean hemoglobin levels and hematocrit 
on the 3rd and 5th day in both groups were still 
within normal limit, which is consistent with the 
study conducted by Priyadarshini et al.19 The 
absence of hemoconcentration in our study is 
probably due to fluid intervention during early 
treatment. Leukopenia has occurred on the 3rd 
day of fever in both groups.
In dengue infection, leukopenia usually 
occurs earlier than thrombocytopenia.1 
Thrombocytopenia had been identified on 
the 3rd day of fever in both groups and it was 
getting more severe on the 5th day of fever. 
Thrombocytopenia commonly occurs in DF 
and is always found in DHF/DSS.1 In the group 
with plasma leakage, we found that the mean 
albumin levels on the 5th day of fever was lower 
than normal. It is consistent with the theory that 
plasma leakage of DHF occurs during the critical 
phase, which is characterized by albumin loss to 
the extravascular space due to increased capillary 
permeability.20 It was found that the mean of 
delta albumin in the group with plasma leakage 
was more than 0.5 g/dL. It is consistent with the 
WHO criteria1 on the markers of plasma leakage 
in DHF patients.
In our study, there was no difference of IL-6 
levels between both groups on the 3rd day of 
fever; while on the 5th day of fever, there was a 
higher levels of IL-6 in the group with plasma 
leakage compared to the group without plasma 
leakage. Various results of previous studies 
show different findings due to different range 
of study design, time set for sample collection 
and different population of patients and clinical 
classification. Priyadarshini et al19 found higher 
IL-6 levels in DHF group compared to the DF 
group. Kumar et al21 and Mangione et al12 found 
that the IL-6 levels in the DHF group was not 
different from the levels in the DF group. Results 
of our study showed that IL-6 may have role in 
the development of plasma leakage in dengue 
infection. However, the effect of various other 
factors that has not been studies should also 
be considered including the cytokines and 
other inflammatory mediators, cellular and 
humoral immune factors, virus virulence and 
susceptibility of host genetic.22
The CRP levels on the 3rd and 5th day of 
fever was found higher in the group with plasma 
leakage compared to the group without plasma 
leakage. It indicates that there is more severe 
inflammatory process in the group with plasma 
leakage, either in the febrile or critical phase. 
However, differences in CRP levels between 
both groups on the 3rd day of fever were not 
accompanied by different IL-6 levels. It may 
occur since there is still an effect of TNF-α and 
IL-1β on CRP synthesis in the liver during the 
febrile phase.
The results of our study have confirmed 
the pathophysiology of the cytokine storm in 
dengue infection of adult patients. It is obvious 
that the cytokine storm reaction occurs in 
the febrile phase and it is resolved during the 
critical phase with an impact of plasma leakage 
in critical phase. According to Guabiraba et 
al.23, there is cytokine storm with high levels 
of pro-inflammatory cytokines in DHF/DSS 
patients, which will be followed by activation of 
coagulation system, acute phase proteins, soluble 
receptor and other inflammatory mediators with 
end results of endothelial activation, vascular 
leakage, which are accompanied by bleeding 
and shock.23
Our study also found that IL-6 levels on the 
3rd day was higher than on the 5th day of fever, 
both in the group with and without plasma 
leakage. It indicates that during the critical phase, 
the inflammatory process has been resolved in 
both groups. However, the IL-6 levels on the 
5th day of fever was still higher in the group 
with plasma leakage compared to the group 
without plasma leakage. It demonstrates that 
IL-6 released during the febrile phase has equal 
strength in both groups, but the recovery process 
in the group with plasma leakage was slower; 
therefore, during the critical phase, we found 
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higher IL-6 levels compared to the group without 
plasma leakage. According to Chaturvedi et 
al.5, if there is a shift of cytokine response to 
Th2 cytokines in dengue infection, which is 
characterized by a very high IL-6 production, 
then plasma leakage will occur. 
Consistent with various previous studies, 
CRP levels were found higher on the 3rd day 
compared to the 5th day of fever in both groups. 
Nascimento et al.24 reported that in the DFH 
and DF groups, there are higher levels of CRP 
than the healthy control. Kumar et al.21 found 
that during the febrile phase, the CRP levels in 
DHF and DF groups are higher than the control 
group; while during the critical phase it is not 
different from the control. It indicates that there 
is more severe inflammatory process in dengue 
infection during the febrile phase compared to 
the critical phase.
CRP is one of acute phase proteins that 
will have increasing levels when inflammation 
occurs. In systemic viral infection, increased 
CRP levels may also occur.13 During the febrile 
phase in dengue infection, there will be viremia 
that can induce acute inflammatory process, 
which is accompanied by increased CRP levels.3,9 
It is consistent with the basic function of CRP, i.e. 
to control inflammation, clearance stimulation 
of damaged cells and tissue component and to 
initiate the repair function.25 Different CRP levels 
on the 3rd and 5th day of fever in both groups 
probably happened due to inflammatory reaction 
on the dengue virus itself, instead of secondary 
bacterial infection since we found reduced CRP 
levels on the 5th day of fever in both groups and 
during hospitalization, no subjects had received 
antibiotic treatment.
The limitation of our study that can affect 
the results is that we did not measure the 
levels of cytokines that induce synthesis of 
other CRPs, i.e. the TNF-α and IL-1β. In 
addition, the USG examination also did not 
measure other parameters for plasma leakage, 
which are thickening of gall bladder wall 
and pericardial effusion; therefore, there is a 
possibility of undetected plasma leakage in our 
study. Although we used secondary data, but 
there is small possibility of recall bias in our 
study since the subjects with incomplete data has 
been excluded from our study. The possibility 
of inaccurate measurement on duration of fever 
is also small because all of medical records in 
accessible population have been completed with 
CRF compiled by an experienced clinical team. 
Moreover, the USG examination to detect the 
presence of pleural effusion and ascites was 
performed by an experienced USG expert to 
avoid the inter-observer bias.
Results of our study can be applied in larger 
populations by evaluating generalizations. 
External validity of our study was relatively good 
since the subjects were recruited by consecutive 
sampling for approximately a year; therefore, we 
believe that it may represent all cases of dengue 
infection all year long. The second external 
validity of our study was also relatively good 
since the characteristics of patients with dengue 
infection who were hospitalized in both hospitals 
were not different from the dengue infection 
patients of other hospitals. Based on the above 
mentioned explanation, we suggest that the 
generalization of our study results can be done 
for adult patients with dengue infection who are 
hospitalized in all hospitals.
CONCLUSION
On the 3rd day of fever, the IL-6 levels were 
not different between the group of adult dengue 
infection patients with and without plasma 
leakage; while on the 5th of fever, the IL-6 levels 
were higher in the group with plasma leakage. 
The levels of IL-6 and CRP in both groups were 
higher on the 3rd day compared to the 5th day of 
fever. The clinical application of our study is 
that measurements of CRP levels can support 
the management of adult patients with dengue 
infection through increasing awareness on the 
development of plasma leakage. 
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